Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Facial fractures in children.
Holland AJ, Broome C, Steinberg A, Cass DT. Holland AJ, et al. Among authors: broome c. Pediatr Emerg Care. 2001 Jun;17(3):157-60. doi: 10.1097/00006565-200106000-00002. Pediatr Emerg Care. 2001. PMID: 11437137
Thrombotic thrombocytopenic purpura masquerading as Evans syndrome.
Mudra SE, Ardoin K, Aggarwal V, Diltz G, Alcedo Andrade PE, Broome CM. Mudra SE, et al. Among authors: broome cm. Am J Hematol. 2024 Dec;99(12):2381-2385. doi: 10.1002/ajh.27476. Epub 2024 Sep 16. Am J Hematol. 2024. PMID: 39282789 No abstract available.
Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension.
Röth A, Broome CM, Barcellini W, Jilma B, Hill QA, Cella D, Anderson Tvedt TH, Yamaguchi M, Murakhovskaya I, Lee M, Shafer F, Wardęcki M, Jayawardene D, Yoo R, Msihid J, Weitz IC. Röth A, et al. Among authors: broome cm. EClinicalMedicine. 2024 Jul 18;74:102732. doi: 10.1016/j.eclinm.2024.102732. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39114274 Free PMC article.
Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B.
Röth A, Berentsen S, Barcellini W, D'Sa S, Jilma B, Michel M, Weitz IC, Yamaguchi M, Nishimura JI, Vos JMI, Cid J, Storek M, Wong N, Yoo R, Jayawardene D, Srivastava S, Wardęcki M, Shafer F, Lee M, Broome CM. Röth A, et al. Among authors: broome cm. EClinicalMedicine. 2024 Jul 18;74:102733. doi: 10.1016/j.eclinm.2024.102733. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39091672 Free PMC article.
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.
Samples L, Voutsinas J, Fakhri B, Khajavian S, Spurgeon S, Stephens D, Skarbnik A, Mato A, Broome C, Gopal A, Smith S, Lynch R, Rainey M, Kim MS, Barrett-Campbell O, Hemond E, Tsang M, Ermann D, Malakhov N, Rao D, Shakib-Azar M, Morrigan B, Chauhan A, Plate T, Gooley T, Ryan K, Lansigan F, Hill B, Pongas G, Parikh SA, Roeker L, Allan JN, Cheng R, Ujjani C, Shadman M. Samples L, et al. Among authors: broome c. Blood Adv. 2024 May 14;8(9):2085-2093. doi: 10.1182/bloodadvances.2023011569. Blood Adv. 2024. PMID: 38315043 Free PMC article.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
251 results